Delivery Order SPE2DB22D3501-SPE2DB25FXK26
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,598.16 to AmerisourceBergen Drug Corp for Norditropin FlexPro 10 mg/1.5 mL pharmaceutical supplies. This competitive award, issued on July 15, 2025, with an ultimate completion date of July 16, 2025, represents a firm fixed-price delivery order with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as...
- The Defense Logistics Agency awarded a delivery order valued at $3,700.78 to AmerisourceBergen Drug Corp for Norditropin FlexPro 10 mg/1.5 mL pharmaceutical product on August 22, 2025, with an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,806.98 to AmerisourceBergen Drug Corp for Norditropin FlexPro 10 mg/1.5 mL pharmaceutical product on August 25, 2025, with completion scheduled for August 26, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $2,618.70 to AmerisourceBergen Drug Corp for Norditropin FlexPro 15 mg/1.5 mL pharmaceutical product. The contract employs firm fixed pricing and was competitively awarded without set-aside restrictions, with an ultimate completion date of September 11, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the...
- The Defense Logistics Agency awarded a delivery order valued at $1,396.92 to AmerisourceBergen Drug Corp for Norditropin FlexPro 15 mg/1.5 mL pharmaceutical product, with an ultimate completion date of June 23, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $3,912.70 to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Norditropin FlexPro 10 mg/1.5 mL injectables. This competitively awarded, firm fixed-price contract is scheduled for completion by September 12, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order was issued without set-aside designation and represents a routine pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $2,375.41 to AmerisourceBergen Drug Corp for Norditropin FlexPro 10 mg/1.5 mL pharmaceutical product, with a firm fixed price arrangement. The contract was competitively awarded without set-aside designation and is scheduled for completion by September 17, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a total...
- The Defense Logistics Agency awarded a $4,062.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Norditropin FlexPro 15 mg/1.5 mL pharmaceutical products, with an ultimate completion date of September 11, 2025. This non-set-aside competitive award was issued on September 10, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- The Defense Logistics Agency awarded a delivery order valued at $2,095.38 to AmerisourceBergen Drug Corp for Norditropin FlexPro 15 mg/1.5 mL on August 15, 2025, with completion scheduled for August 18, 2025. The contract employs firm fixed pricing and was awarded without set-aside designation through competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a single...
- The Defense Logistics Agency awarded a $4,777.07 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for Norditropin FlexPro 10 mg/1.5 mL pharmaceutical product, with a completion date of August 7, 2025. This non-set-aside contract was competitively awarded and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXK26Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,243.97 to AmerisourceBergen Drug Corp for Norditropin FlexPro 10 mg/1.5 ml pharmaceutical product, with a completion date of September 18, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. The prime IDC enables the contractor to supply a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains to support military healthcare programs worldwide. The contract structure reflects DLA's strategic approach to pharmaceutical procurement, allowing flexibility in fulfilling requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 9/17/25 |